Friday, July 10, 2026

pharma · Leukemia · Acute Myeloid Leukemia

Shanghai Medical College

Shanghai Medical College clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
20 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
20
Programs
20
Drugs
22
Patents
0
Intelligence · Clinical Programs

Shanghai Medical College projects

1 ClinicalTrials.gov programs sponsored by Shanghai Medical College.

Shanghai Medical College has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. imatinib mesylate

    Children's Hospital of Fudan University

    Leukemia

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does Shanghai Medical College have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.